Former senior NHS Chief Executive joins Zellar advisory committee
Renowned healthcare leader to steer Zellar’s healthcare offering
Zellar, the online sustainability platform is proud to announce the appointment of Sir Andrew Cash, a former senior NHS Chief Executive, to its advisory committee.
In his new capacity as an advisor, Andrew will play a pivotal role in shaping and advancing Zellar's NHS pilot programme, a pioneering initiative aimed at exploring the platform's potential in supporting a diverse range of NHS services.
With over three decades of leadership within the NHS, spanning various tiers from local to national, Andrew brings a wealth of unique experience to Zellar - including several appointments at the Department of Health and Social Care.
A trailblazing figure in healthcare management, Andrew steered the Sheffield Teaching Hospitals NHS Foundation Trust from its inception in 2004 until 2018, solidifying his reputation as a visionary leader. His contributions extended to spearheading an Integrated Care System and assuming the role of non-executive chair of an Integrated Care Board.
Sir Andrew commented: "I’m honoured to contribute to the advisory committee and channel my expertise towards building solutions for advancing sustainability in healthcare. The collaboration between Zellar and the NHS presents an exceptional opportunity to address challenges and chart a course toward achieving net zero objectives. It's imperative that we unite our efforts to secure a sustainable future."
Zellar CEO and founder, Gary Styles, added, "Welcoming Sir Andrew Cash to our advisory committee is a watershed moment. His unparalleled experience will undoubtedly help us to propel our sustainability solution for the healthcare sector forward.'’
Andrew has chaired numerous institutions such as the National NHS Foundation Trust Network, the NHS Employers Policy Board, and the NHS Confederation. He currently holds positions on the global executive group of St John Ambulance and serves as chair of the St John Eye Hospital Group in Jerusalem. His substantial contributions were recognised with an OBE in 2001, followed by a knighthood for his pivotal role in healthcare advancement in 2009.